Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ADAP - Adaptimmune Therapeutics plc
880 K
LAST VALUE
-48.27%
2 YEAR CAGR
-61.40%
5 YEAR CAGR
-13.40%
10 YEAR CAGR